Capricor Therapeutics (CAPR) Non-Current Debt (2016 - 2024)
Historic Non-Current Debt for Capricor Therapeutics (CAPR) over the last 12 years, with Q3 2024 value amounting to $3.4 million.
- Capricor Therapeutics' Non-Current Debt changed 0.0% to $3.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.4 million for FY2023, which is 0.0% changed from last year.
- Per Capricor Therapeutics' latest filing, its Non-Current Debt stood at $3.4 million for Q3 2024, which was down 0.0% from $3.4 million recorded in Q2 2024.
- In the past 5 years, Capricor Therapeutics' Non-Current Debt registered a high of $3.4 million during Q1 2020, and its lowest value of $3.4 million during Q1 2020.
- Over the past 5 years, Capricor Therapeutics' median Non-Current Debt value was $3.4 million (recorded in 2020), while the average stood at $3.4 million.
- Examining YoY changes over the last 5 years, Capricor Therapeutics' Non-Current Debt showed a top increase of 0.0% in 2020 and a maximum decrease of 0.0% in 2020.
- Capricor Therapeutics' Non-Current Debt (Quarter) stood at $3.4 million in 2020, then changed by 0.0% to $3.4 million in 2021, then changed by 0.0% to $3.4 million in 2022, then changed by 0.0% to $3.4 million in 2023, then changed by 0.0% to $3.4 million in 2024.
- Its last three reported values are $3.4 million in Q3 2024, $3.4 million for Q2 2024, and $3.4 million during Q1 2024.